MTO1 binds to TRAF4 as a competitive endogenous RNA (ceRNA) in MCF-7 and MDA-MB-231, leading to decreased Ki-67 expression, inhibiting tumor activity, and reversing chemotherapeutic drug resistance (55). The gene discussed is TRAF4; the disease is neoplasm.